Clinical Trial Update: Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating TPV/r (tipranavir/ritonavir) in subjects with mild to moderate hepatic impairment to assess how liver function affect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency

Drugs mentioned

• tipranavir/ritonavir (tipranavir/ritonavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED